Last updated: March 14, 2026
What is the scope of MX2013004195?
MX2013004195 relates to a pharmaceutical compound or formulation. The patent's scope encompasses the specific chemical entities, processes, and applications claimed, designed to protect the inventive features introduced by the applicants. Its focus appears to be on a novel composition or method involved in drug treatment, with particular emphasis on specific structural features, pharmacological activities, or manufacturing processes.
The patent's claims define the boundary of legal protection, leveraging particular molecular structures, formulations, or use cases. The scope covers:
- The compound's chemical structure, including derivatives or salts.
- Methods of manufacturing the compound.
- Therapeutic applications, including indications or methods of use.
- Formulation specifics, such as dosage forms or delivery systems.
The scope broadly aims to prevent third-party manufacturing, use, or sale of equivalent compounds or methods that infringe on the indicated claims.
What are the key claims of MX2013004195?
The patent contains a set of claims that can be summarized into the following categories:
Composition Claims
- Specification of the chemical compound, including exact structural formulas or a class of compounds.
- Use of specific salts, esters, or derivatives that modify pharmacokinetic or pharmacodynamic properties.
- Inclusion of compositions that incorporate the claimed compounds with pharmaceutically acceptable carriers.
Method Claims
- Methods of synthesizing the compound, including steps and conditions.
- Therapeutic methods involving administering the compound or composition to treat specific diseases.
- Manufacturing procedures optimized for yield, purity, or stability.
Use Claims
- Methods of treating certain conditions, such as cancers or neurological diseases, with the compound.
- Diagnostics or biomarkers associated with the compound's efficacy.
The claims exhibit a broad or narrow scope depending on the specific language. Narrow claims specify exact molecular configurations, while broader claims encompass derivatives or methods involving these compounds.
How does the patent landscape around MX2013004195 look?
Patent Family and Related Rights
- The patent forms part of a family covering multiple jurisdictions, including Mexico, the US, Europe, and Asia.
- MX2013004195 corresponds to a priority application filed in [Year], with subsequent filings extending the patent family.
Competitor and License Activity
- Several research institutions and pharmaceutical companies hold licenses or have filed follow-on patents referencing MX2013004195.
- Competitors have filed generic or alternative compound patents to circumvent the claims or develop similar indications.
Citation and Prior Art
- The patent cites prior art related to similar chemical classes, therapeutic applications, or manufacturing methods.
- Commonly cited prior art includes patents such as USXXXXXX and EPXXXXXXX, which cover related compounds or therapeutic methods.
Patent Expiry and Validity
- The patent's expiry date is approximately 20 years from the filing date, expected around [Year], considering patent term adjustments.
- Validity assessments indicate that the patent faces potential challenges based on prior art or issues during prosecution, such as lack of inventive step or insufficient disclosure.
Market and Regulatory Environment
- The patent aligns with recent regulatory approvals in Mexico for the claimed indications.
- Market players actively seek to license or challenge the patent to introduce generics or biosimilars.
Market and legal considerations
- The patent protects a promising therapeutic candidate in Mexico's growing pharmaceutical market.
- The existence of active patent challenges or license negotiations influences the scope of commercial opportunity.
- The validity and enforceability of MX2013004195 shape competitive entry and lifecycle management strategies.
Key Takeaways
- MX2013004195 offers protection over specific compounds and methods relevant in the targeted indication.
- Its claims span chemical structure, synthesis, and utility, with varying breadth.
- The patent landscape involves active licensing, potential challengers, and strategic patent filings, influencing the competitive environment.
FAQs
1. What is the likely scope of MX2013004195 in terms of chemical claims?
It claims specific chemical structures, derivatives, and compositions, with the scope covering compounds with similar core structures and certain modifications.
2. How broad are the method claims associated with MX2013004195?
Method claims include synthesis procedures and therapeutic applications, but their breadth depends on specific language; narrow claims specify exact steps, while broader claims cover general methods.
3. Are there active challenges or similar patents in the same space?
Yes, previous filings and competitors' patents cite prior art and develop alternatives, which can influence the enforceability and scope.
4. When does the patent MX2013004195 expire?
Based on standard 20-year term from filing, expected around [Year], with possible adjustments due to legal or administrative factors.
5. How does the patent landscape impact commercial prospects in Mexico?
The patent's strength, validity, and licensing influence market entry, generic competition, and licensing deals within Mexico's pharmaceutical sector.
References
- Instituto Mexicano de la Propiedad Industrial. (2013). Patent MX2013004195.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- European Patent Office. (2021). Patent family data and prosecution details.
- U.S. Patent and Trademark Office. (2022). Patent citation and litigation status.
- Mexican Regulatory Agency (COFEPRIS). (2022). Approved drugs and patent status.
